maprotiline and venlafaxine hydrochloride

maprotiline has been researched along with venlafaxine hydrochloride in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (60.00)29.6817
2010's1 (20.00)24.3611
2020's1 (20.00)2.80

Authors

AuthorsStudies
Harvey, AT; Preskorn, SH; Rudolph, RL1
Jacob, C; Luckhaus, C1
Bertolín-Guillén, JM; Climent-Díaz, B; Navarré-Gimeno, A1
Cavender, HM; Cooke, JD; Grover, LM; Lima, HK1
Giles, R; Girard, MFC; Hopfgartner, G; Knight, P1

Other Studies

5 other study(ies) available for maprotiline and venlafaxine hydrochloride

ArticleYear
Evidence of the dual mechanisms of action of venlafaxine.
    Archives of general psychiatry, 2000, Volume: 57, Issue:5

    Topics: Adolescent; Adrenergic Uptake Inhibitors; Adult; Antidepressive Agents, Second-Generation; Biological Transport, Active; Blood Platelets; Blood Pressure; Cyclohexanols; Dose-Response Relationship, Drug; Electrocardiography; Heart Rate; Humans; Injections, Intravenous; Male; Maprotiline; Middle Aged; Norepinephrine; Selective Serotonin Reuptake Inhibitors; Serotonin; Sertraline; Systole; Tyramine; Venlafaxine Hydrochloride

2000
Venlafaxine withdrawal syndrome not prevented by maprotiline, but resolved by sertraline.
    The international journal of neuropsychopharmacology, 2001, Volume: 4, Issue:1

    Topics: Aged; Antidepressive Agents, Second-Generation; Cyclohexanols; Female; Humans; Maprotiline; Nausea; Selective Serotonin Reuptake Inhibitors; Sertraline; Sleep Initiation and Maintenance Disorders; Substance Withdrawal Syndrome; Venlafaxine Hydrochloride

2001
Serotonin syndrome due to association of venlafaxine, maprotiline and reboxetine.
    European psychiatry : the journal of the Association of European Psychiatrists, 2004, Volume: 19, Issue:7

    Topics: Cyclohexanols; Depressive Disorder; Emergency Medical Services; Humans; Male; Maprotiline; Middle Aged; Morpholines; Reboxetine; Selective Serotonin Reuptake Inhibitors; Serotonin Syndrome; Venlafaxine Hydrochloride

2004
Antidepressants that inhibit both serotonin and norepinephrine reuptake impair long-term potentiation in hippocampus.
    Psychopharmacology, 2014, Volume: 231, Issue:23

    Topics: Adrenergic Uptake Inhibitors; Animals; Antidepressive Agents; Brain-Derived Neurotrophic Factor; Cyclohexanols; Fluoxetine; Hippocampus; Imipramine; Long-Term Potentiation; Male; Maprotiline; Norepinephrine; Selective Serotonin Reuptake Inhibitors; Serotonin; Synaptic Transmission; Venlafaxine Hydrochloride

2014
Effects of the LC mobile phase in vacuum differential mobility spectrometry-mass spectrometry for the selective analysis of antidepressant drugs in human plasma.
    Analytical and bioanalytical chemistry, 2022, Volume: 414, Issue:24

    Topics: Acetonitriles; Amitriptyline; Antidepressive Agents; Desipramine; Humans; Imipramine; Maprotiline; Mass Spectrometry; Methanol; Nortriptyline; Reproducibility of Results; Spectrum Analysis; Vacuum; Venlafaxine Hydrochloride

2022